----

----

**FORM      10-Q**

| For                quarter ended: September 30, 2005 | Commission                File No. 0-11178 |
|------------------------------------------------------|--------------------------------------------|

| UTAH                                                                          | 87-0342734                                          |
|-------------------------------------------------------------------------------|-----------------------------------------------------|
| (State                or other jurisdiction of incorporation or organization) | (I.R.S.                Employer Identification No.) |

----

| PART                I - FINANCIAL INFORMATION | PAGE                                                                               |
|-----------------------------------------------|------------------------------------------------------------------------------------|
|                                          |                                                                               |   |   |   |
|                                          | Item                1.                                                             | Financial                Statements |   |   |
|                                          |                                                                               |   |   |   |
|                                          |  Consolidated                Condensed Balance Sheets as of                   |   |   |
|                                          |  September                30, 2005 and December 31, 2004                      | 1 |   |
|                                          |                                                                               |   |   |
|                                          |  Consolidated                Condensed Statements of Income for the three and |   |   |
|                                          |  nine                months ended September 30, 2005 and September 30, 2004   | 2 |   |
|                                          |                                                                               |   |   |
|                                          |  Consolidated                Condensed Statements of Cash Flows for the       |   |   |
|                                          |  nine                months ended September 30, 2005 and September 30, 2004   | 3 |   |
|                                          |                                                                               |   |   |
|                                          |  Notes                to Consolidated Condensed Financial Statements          | 5 |   |
|                                          |                                                                               |   |   |   |
|                                          | Item                2.                                                             | Management’s                Discussion and Analysis of |   |   |
|                                          |                                                                               | Financial                Condition and Results of Operations | 8 |   |
|                                          |                                                                               |   |   |   |
|                                          | Item                3.                                                             | Quantitative                and Qualitative Disclosures about Market Risk | 12 |   |
|                                          |                                                                               |   |   |   |
|                                          | Item                4.                                                             | Controls                and Procedures | 12 |   |
|                                          |                                                                               |   |   |   |
| PART                II - OTHER INFORMATION    |                                                                               |   |
|                                          |                                                                               |   |   |   |
|                                          | Item                1.                                                             | Legal                Proceedings | 13 |   |
|                                          |                                                                               |   |   |   |
|                                          | Item                2.                                                             | Unregistered                Sales of Equity Securities and Use of Proceeds | 13 |   |
|                                          |                                                                               |   |   |   |
|                                          | Item                6.                                                             | Exhibits | 14 |   |
|                                          |                                                                               |   |   |   |
| SIGNATURES                                    | 14                                                                                 |   |

----

PART      I -      FINANCIAL INFORMATION

**Item      1. Financial Statements**

|                                                                      |   | (unaudited)                       |   | (audited)                        |   |
|---------------------------------------------------------------------------|--------|-----------------------------------|--------|----------------------------------|--------|
| ASSETS                                                                    |   | SEPTEMBER                30, 2005 |   | DECEMBER                31, 2004 |   |
|                                                                      |   |                              |   |                             |   |
| Current                assets:                                            |   |                              |   |                             |   |
| Cash                                                                      |   | $                                 | 1,511  |                             | $      | 1,818 |   |
| Investments,                available-for-sale                            |   |                              | 12,069 |                             |   | 15,110 |   |
| Accounts                receivable - net                                  |   |                              | 3,467  |                             |   | 3,730 |   |
| Inventories                                                               |   |                              | 3,117  |                             |   | 2,859 |   |
| Other                current assets                                       |   |                              | 923    |                             |   | 1,013 |   |
|  Total                current assets                                 |   |                              | 21,087 |                             |   | 24,530 |   |
|                                                                      |   |                              |   |                             |   |   |   |
| Property                and equipment - net                               |   |                              | 8,301  |                             |   | 9,058 |   |
|                                                                      |   |                              |   |                             |   |   |   |
| Goodwill                                                                  |   |                              | 7,191  |                             |   | 7,191 |   |
|                                                                      |   |                              |   |                             |   |   |   |
| Other                intangible assets                                    |   |                              | 2,718  |                             |   | 2,718 |   |
| Other                intangible assets - accumulated amortization         |   |                              | (2,272 | )                                |   | (2,235 | ) |
|  Other                intangible assets - net                        |   |                              | 446    |                             |   | 483 |   |
|                                                                      |   |                              |   |                             |   |   |   |
|  TOTAL                                                               |   | $                                 | 37,025 |                             | $      | 41,262 |   |
|                                                                      |   |                              |   |                             |   |   |   |
| LIABILITIES                AND STOCKHOLDERS' EQUITY                       |   |                              |   |                             |   |   |   |
|                                                                      |   |                              |   |                             |   |   |   |
| Current                liabilities:                                       |   |                              |   |                             |   |   |   |
| Accounts                payable                                           |   | $                                 | 816    |                             | $      | 698 |   |
| Accrued                expenses                                           |   |                              | 2,353  |                             |   | 3,638 |   |
|  Total                current liabilities                            |   |                              | 3,169  |                             |   | 4,336 |   |
|                                                                      |   |                              |   |                             |   |   |   |
| Deferred                income taxes                                      |   |                              | 316    |                             |   | 769 |   |
|                                                                      |   |                              |   |                             |   |   |   |
|  Total                liabilities                                    |   |                              | 3,485  |                             |   | 5,105 |   |
|                                                                      |   |                              |   |                             |   |   |   |
| Commitments                and contingencies                              |   |                              | -      |                             |   | - |   |
|                                                                      |   |                              |   |                             |   |   |   |
| Stockholders'                equity:                                      |   |                              |   |                             |   |   |   |
| Preferred                stock - $.01 par value; authorized - 5,000       |   |                              |   |                             |   |   |   |
| shares;                no shares issued or outstanding                    |   |                              |   |                             |   |   |   |
| Common                stock - $.01 par value; authorized - 50,000         |   |                              |   |                             |   |   |   |
| shares;                issued - September 30, 2005, 3,882 shares          |   |                              |   |                             |   |   |   |
| December                31, 2004, 4,105 shares                            |   |                              | 39     |                             |   | 41 |   |
| Accumulated                other comprehensive income                     |   |                              | (558   | )                                |   | 226 |   |
| Retained                earnings                                          |   |                              | 34,059 |                             |   | 35,890 |   |
|  Total                stockholders' equity                           |   |                              | 33,540 |                             |   | 36,157 |   |
|                                                                      |   |                              |   |                             |   |   |   |
|  TOTAL                                                               |   | $                                 | 37,025 |                             | $      | 41,262 |   |
|                                                                      |   |                              |   |                             |   |   |   |
| *see                notes to consolidated condensed financial statements* |   |                              |   |                             |   |   |   |

----

|                                                                      |   | THREE                MONTHS ENDED |   | NINE                MONTHS ENDED |   |
|---------------------------------------------------------------------------|--------|-----------------------------------|--------|----------------------------------|--------|
|                                                                      |   | SEPTEMBER                30,      |   | SEPTEMBER                30,     |   |
|                                                                      |   | 2005                              |   | 2004                             |   | 2005 |   | 2004 |   |
| NET                SALES                                                  |   | $                                 | 7,001  |                             | $      | 6,670 |   | $ | 20,681 |   | $ | 20,113 |   |
|                                                                      |   |                              |   |                             |   |   |   |   |   |   |   |   |   |
| COST                OF SALES                                              |   |                              | 2,987  |                             |   | 2,891 |   |   | 8,911 |   |   | 8,550 |   |
|                                                                      |   |                              |   |                             |   |   |   |   |   |   |   |   |   |
|  Gross                Margin                                         |   |                              | 4,014  |                             |   | 3,779 |   |   | 11,770 |   |   | 11,563 |   |
|                                                                      |   |                              |   |                             |   |   |   |   |   |   |   |   |   |
| OPERATING                EXPENSES:                                        |   |                              |   |                             |   |   |   |   |   |   |   |   |   |
|                                                                      |   |                              |   |                             |   |   |   |   |   |   |   |   |   |
| Selling,                general and administrative                        |   |                              | 1,894  |                             |   | 1,148 |   |   | 4,484 |   |   | (2,183 | ) |
| Research                & development                                 |   |                              | 82     |                             |   | 70 |   |   | 225 |   |   | 217 |   |
|  Total                                                               |   |                              | 1,976  |                             |   | 1,218 |   |   | 4,709 |   |   | (1,966 | ) |
|                                                                      |   |                              |   |                             |   |   |   |   |   |   |   |   |   |
|  Income                from Operations                               |   |                              | 2,038  |                             |   | 2,561 |   |   | 7,061 |   |   | 13,529 |   |
|                                                                      |   |                              |   |                             |   |   |   |   |   |   |   |   |   |
| OTHER                INCOME                                               |   |                              | 203    |                             |   | 189 |   |   | 670 |   |   | 521 |   |
|                                                                      |   |                              |   |                             |   |   |   |   |   |   |   |   |   |
|  Income                Before Income Tax Expense                     |   |                              | 2,241  |                             |   | 2,750 |   |   | 7,731 |   |   | 14,050 |   |
|                                                                      |   |                              |   |                             |   |   |   |   |   |   |   |   |   |
| INCOME                TAX EXPENSE                                         |   |                              | 452    |                             |   | 943 |   |   | 2,086 |   |   | 5,227 |   |
|                                                                      |   |                              |   |                             |   |   |   |   |   |   |   |   |   |
| Net                Income                                                 |   | $                                 | 1,789  |                             | $      | 1,807 |   | $ | 5,645 |   | $ | 8,823 |   |
|                                                                      |   |                              |   |                             |   |   |   |   |   |   |   |   |   |
| BASIC                EARNINGS PER SHARE                                   |   | $                                 | 0.46   |                             | $      | 0.41 |   | $ | 1.41 |   | $ | 1.97 |   |
|                                                                      |   |                              |   |                             |   |   |   |   |   |   |   |   |   |
| DILUTED                EARNINGS PER SHARE                                 |   | $                                 | 0.44   |                             | $      | 0.39 |   | $ | 1.34 |   | $ | 1.85 |   |
|                                                                      |   |                              |   |                             |   |   |   |   |   |   |   |   |   |
| SHARES                OUTSTANDING - BASIC                                 |   |                              | 3,882  |                             |   | 4,428 |   |   | 3,995 |   |   | 4,479 |   |
|                                                                      |   |                              |   |                             |   |   |   |   |   |   |   |   |   |
| SHARES                OUTSTANDING - DILUTED                               |   |                              | 4,104  |                             |   | 4,674 |   |   | 4,219 |   |   | 4,770 |   |
|                                                                      |   |                              |   |                             |   |   |   |   |   |   |   |   |   |
| *see                notes to consolidated condensed financial statements* |   |                              |   |                             |   |   |   |   |   |

----

|                                                                      |   | SEPTEMBER                30, |   |
|---------------------------------------------------------------------------|--------|------------------------------|--------|
|                                                                      |   | 2005                         |   | 2004 |   |
| CASH                FLOWS FROM OPERATING ACTIVITIES:                      |   |                         |   |   |   |
| Net                income                                                 |   | $                            | 5,645  |   | $ | 8,823 |   |
| Adjustments                to reconcile net income to net                 |   |                         |   |   |   |   |   |
| cash                provided by operating activities:                     |   |                         |   |   |   |   |   |
| Depreciation                and amortization                              |   |                         | 514    |   |   | 616 |   |
| Gain                on investments                                        |   |                         | (70    | ) |   | - |   |
| Recovery                of losses on accounts receivable                  |   |                         | (6     | ) |   | (1 | ) |
| Loss                on disposal of assets                                 |   |                         | -      |   |   | 5 |   |
| Deferred                income taxes                                      |   |                         | (330   | ) |   | 137 |   |
| Tax                benefit attributable to exercise of stock options      |   |                         | 255    |   |   | 399 |   |
| Changes                in operating assets and liabilities:               |   |                         |   |   |   |   |   |
| Accounts                receivable - trade                                |   |                         | 49     |   |   | (14 | ) |
| Accrued                interest and other receivables                     |   |                         | 88     |   |   | 115 |   |
| Litigation                receivable                                      |   |                         | -      |   |   | 24,884 |   |
| Inventories                                                               |   |                         | (414   | ) |   | 185 |   |
| Prepaid                expenses and other current assets                  |   |                         | (13    | ) |   | (25 | ) |
| Accounts                payable                                           |   |                         | 138    |   |   | 179 |   |
| Accrued                expenses                                           |   |                         | (1,243 | ) |   | (9,042 | ) |
|  Total                adjustments                                    |   |                         | (1,032 | ) |   | 17,438 |   |
|  Net                cash provided by operating activities            |   |                         | 4,613  |   |   | 26,261 |   |
|                                                                      |   |                         |   |   |   |   |   |
| CASH                FLOWS FROM INVESTING ACTIVITIES:                      |   |                         |   |   |   |   |   |
| Capital                expenditures for:                                  |   |                         |   |   |   |   |   |
| Property                and equipment                                     |   |                         | (286   | ) |   | (351 | ) |
| Intangible                assets                                          |   |                         | -      |   |   | (10 | ) |
| Purchases                of investments                                   |   |                         | (4,100 | ) |   | (22,103 | ) |
| Proceeds                from the sale of investments                      |   |                         | 7,202  |   |   | 4,248 |   |
| Net                cash paid in acquisition                               |   |                         | -      |   |   | (1,012 | ) |
|  Net                cash provided by (used in) investing activities  |   |                         | 2,816  |   |   | (19,228 | ) |
|                                                                      |   |                         |   |   |   |   |   |
| CASH                FLOWS FROM FINANCING ACTIVITIES:                      |   |                         |   |   |   |   |   |
| Proceeds                from issuance of common stock - options           |   |                         | 646    |   |   | 1,055 |   |
| Common                stock purchased and retired                         |   |                         | (6,503 | ) |   | (6,137 | ) |
| Common                stock purchased and retired - options               |   |                         | (48    | ) |   | (6 | ) |
| Payment                of dividends                                       |   |                         | (1,842 | ) |   | (678 | ) |
|  Net                cash used in financing activities                |   |                         | (7,746 | ) |   | (5,767 | ) |
|                                                                      |   |                         |   |   |   |   |   |
| Effect                of exchange rate changes on cash                    |   |                         | 10     |   |   | (3 | ) |
|                                                                      |   |                         |   |   |   |   |   |
| NET                INCREASE (DECREASE) IN CASH                            |   |                         | (307   | ) |   | 1,262 |   |
|                                                                      |   |                         |   |   |   |   |   |
| CASH                AT BEGINNING OF PERIOD                                |   |                         | 1,818  |   |   | 762 |   |
|                                                                      |   |                         |   |   |   |   |   |
| CASH                AT END OF PERIOD                                      |   | $                            | 1,511  |   | $ | 2,024 |   |
|                                                                      |   |                         |   |   |   |   |   |
|                                                                      |   |                         |   |   |   |   |   |
| *see                notes to consolidated condensed financial statements* |   |                         |   |   |   |   |   |

----

*Continued*

|                                                                                                                                                                                                                                                                                  |   | Nine                Months EndedSEPTEMBER                30, |   |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|--------------------------------------------------------------|--------|
|                                                                                                                                                                                                                                                                                  |   | 2005                                                         |   | 2004 |   |
|                                                                                                                                                                                                                                                                                  |   |                                                         |   |   |   |
| Cash                paid during the period for income taxes                                                                                                                                                                                                                           |   | $                                                            | 2,317  |   | $ | 13,222 |   |
| Cash                paid during the period for interest                                                                                                                                                                                                                               |   | $                                                            | -      |   | $ | - |   |
|                                                                                                                                                                                                                                                                                  |   |                                                         |   |   |   |   |   |
|                                                                                                                                                                                                                                                                                  |   |                                                         |   |   |   |   |   |
| During                the nine months ended September 30, 2004 the Company purchased all                of the                outstanding stock of Abcorp Medical, Inc. The Company paid cash,                and                recorded net assets from the acquisition as follows: |   |                                                         |   |   |   |   |   |
|                                                                                                                                                                                                                                                                                  |   |                                                         |   |   |   |   |   |
| Cash                                                                                                                                                                                                                                                                                  |   |                                                         |   |   | $ | 11 |   |
| Accounts                receivable                                                                                                                                                                                                                                                    |   |                                                         |   |   |   | 127 |   |
| Inventory                                                                                                                                                                                                                                                                             |   |                                                         |   |   |   | 25 |   |
| Prepaid                insurance                                                                                                                                                                                                                                                      |   |                                                         |   |   |   | 18 |   |
| Equipment,                net                                                                                                                                                                                                                                                         |   |                                                         |   |   |   | 16 |   |
| Accounts                payable                                                                                                                                                                                                                                                       |   |                                                         |   |   |   | (96 | ) |
| Accrued                expenses                                                                                                                                                                                                                                                       |   |                                                         |   |   |   | (25 | ) |
| Intangibles                                                                                                                                                                                                                                                                           |   |                                                         |   |   |   | 946 |   |
| Total                cash paid                                                                                                                                                                                                                                                        |   |                                                         |   |   |   | 1,022 |   |
| Less                cash received                                                                                                                                                                                                                                                     |   |                                                         |   |   |   | (11 | ) |
| Net                cash investment                                                                                                                                                                                                                                                    |   |                                                         |   |   | $ | 1,012 |   |
|                                                                                                                                                                                                                                                                                  |   |                                                         |   |   |   |   |   |
|                                                                                                                                                                                                                                                                                  |   |                                                         |   |   |   |   |   |
| *see                notes to consolidated condensed financial statements*                                                                                                                                                                                                             |   |                                                         |   |   |   |   |   |

----

|                          |   | September                30, |   | December                31, |   |
|-------------------------------|--------|------------------------------|--------|-----------------------------|--------|
|                          |   | 2005                         |   | 2004                        |   |
| Finished                goods |   | $                            | 792    |                        | $      | 932 |   |
| Work-in-process               |   |                         | 777    |                        |   | 640 |   |
| Raw                materials  |   |                         | 1,548  |                        |   | 1,287 |   |
| Total                         |   | $                            | 3,117  |                        | $      | 2,859 |   |

|                                                                                                                                                              |   | Three                Months EndedSeptember                30, |   | Nine                Months EndedSeptember                30, |   |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|---------------------------------------------------------------|--------|--------------------------------------------------------------|--------|
|                                                                                                                                                              |   | 2005                                                          |   | 2004                                                         |   | 2005 |   | 2004 |   |
| Net                Income as reported                                                                                                                             |   | $                                                             | 1,789  |                                                         | $      | 1,807 |   | $ | 5,645 |   | $ | 8,823 |   |
| Deduct:                                                                                                                                                           |   |                                                          |   |                                                         |   |   |   |   |   |   |   |   |   |
| Total                stock-based employee compensation expense determined under fair value                based method for all awards, net of related tax effects |   |                                                          | -156   |                                                         |   | -96 |   |   | -768 |   |   | -291 |   |
| Net                income pro forma                                                                                                                               |   | $                                                             | 1,633  |                                                         | $      | 1,711 |   | $ | 4,877 |   | $ | 8,532 |   |
| Earnings                per share:                                                                                                                                |   |                                                          |   |                                                         |   |   |   |   |   |   |   |   |   |
| Basic                - as reported                                                                                                                                |   | $                                                             | 0.46   |                                                         | $      | 0.41 |   | $ | 1.41 |   | $ | 1.97 |   |
| Basic                - pro forma                                                                                                                                  |   | $                                                             | 0.42   |                                                         | $      | 0.39 |   | $ | 1.22 |   | $ | 1.91 |   |
| Diluted                - as reported                                                                                                                              |   | $                                                             | 0.44   |                                                         | $      | 0.39 |   | $ | 1.34 |   | $ | 1.85 |   |
| Diluted                - pro forma                                                                                                                                |   | $                                                             | 0.40   |                                                         | $      | 0.37 |   | $ | 1.16 |   | $ | 1.79 |   |

----

| Beginning                Balance, July 1, 2005                                 |   | $      | 60     |   |
|--------------------------------------------------------------------------------|--------|--------|--------|--------|
| Changes                in Warranty Reserve during 3Q 2005:                     |   |   |   |   |
| Aggregate                reductions for warranty repairs                       |   |   | (1     | )      |
| Aggregate                changes for warranties issued during reporting period |   |   | 6      |   |
| Aggregate                changes in reserve related to preexisting warranties  |   |   | (5     | )      |
| Ending                Balance, September 30, 2005                              |   | $      | 60     |   |

| Investments,                available-for-sale |   | September                30,2005 |   | September                30,2004 |   |
|------------------------------------------------|--------|----------------------------------|--------|----------------------------------|--------|
| Investments,                at cost            |   | $                                | 12,007 |                             | $      | 18,669 |   |
| Equity                Securities:              |   |                             |   |                             |   |   |   |
| Unrealized                holding gains        |   |                             | 135    |                             |   | 41 |   |
| Unrealized                holding (losses)     |   |                             | (73    | )                                |   | (107 | ) |
| Investments,                at fair value      |   | $                                | 12,069 |                             | $      | 18,603 |   |

| Unrealized                holding gains on available-for-sale investments                           |   | 3Q                2005 |   | 3Q                2004 |   |
|-----------------------------------------------------------------------------------------------------|--------|------------------------|--------|------------------------|--------|
| Balance,                beginning of period                                                         |   | $                      | 53     |                   | $      | 26 |   |
| Realized                gain from securities included in beginning balance                          |   |                   | -      |                   |   | - |   |
| Gross                unrealized holding gains, net of (losses), in equity                securities |   |                   | (24    | )                      |   | (109 | ) |
| Deferred                income taxes on unrealized holding gain                                     |   |                   | 9      |                   |   | 43 |   |
| Balance,                end of period                                                               |   | $                      | 38     |                   | $      | (40 | ) |

| Available-for-sale                debt securities |   | September                30,2005 |   | September                30,2004 |   |
|---------------------------------------------------|--------|----------------------------------|--------|----------------------------------|--------|
| Maturity                less than 1 year          |   | $                                | 2,052  |                             | $      | 12,544 |   |
| Maturity                greater than 10 years     |   |                             | 1,425  |                             |   | 1,475 |   |

----

----

**Item      2.**
**Management's      Discussion and Analysis of Financial Condition and Results of      Operations**

|                                                               |   | 3Q                05 |   | 3Q                04 |   |
|--------------------------------------------------------------------|--------|----------------------|--------|----------------------|--------|
| Gross                Profit Margin (gross profits/ sales):         |   |                 | 57.3%  |                 |   | 56.6% |   |
| Operating                Profit Margin (operating profits/ sales): |   |                 | 29.1%  |                 |   | 38.4% |   |
| Net                Income (net profits/ sales):                    |   |                 | 25.6%  |                 |   | 27.1% |   |

|                                                               |   | 9M                05 |   | 9M                04 |   |
|--------------------------------------------------------------------|--------|----------------------|--------|----------------------|--------|
| Gross                Profit Margin (gross profits/ sales):         |   |                 | 56.9%  |                 |   | 57.5% |   |
| Operating                Profit Margin (operating profits/ sales): |   |                 | 34.1%  |                 |   | 67.3% |   |
| Net                Income (net profits/ sales):                    |   |                 | 27.3%  |                 |   | 43.9% |   |

----

|                                                      |   | 3Q                2005 |   | 3Q                2004 |   | 9M                2005 |   | 9M                2004 |   |
|-----------------------------------------------------------|--------|------------------------|--------|------------------------|--------|------------------------|--------|------------------------|--------|
| Labor                & Delivery                       |   | $                      | 2,528  |                   | $      | 2,934                  |   | $                      | 7,332  |   | $ | 8,334 |   |
| Gynecology/                Electrosurgery/ Urology        |   |                   | 1,298  |                   |   | 1,261                  |   |                   | 3,929  |   |   | 3,912 |   |
| Neonatal                                                  |   |                   | 1,861  |                   |   | 1,099                  |   |                   | 4,819  |   |   | 3,116 |   |
| Blood                Pressure Monitoring and Accessories* |   |                   | 1,314  |                   |   | 1,376                  |   |                   | 4,601  |   |   | 4,751 |   |

----

----

----

**Item      3. Quantitative      and Qualitative Disclosures about Market Risk**

**Item      4. Controls and Procedures**

----

**Item      1. **
**Legal      Proceedings**

**Item      2.**
**Unregistered      Sales of Equity Securities and Use of Proceeds**

**ISSUER      PURCHASES OF EQUITY SECURITIES**

| Period                           | Total                Numberof                SharesPurchased                (1) | AveragePrice                Paidper                Share | Total                Number ofShares                Purchased asPart                of PubliclyAnnounced                Plans orPrograms                (1) | Maximum                Number (orApproximate                Dollar Value)of                Shares that May bePurchased                Under the Plans orPrograms                (1) |
|----------------------------------|---------------------------------------------------------------------------------|----------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 7/01/05                - 7/31/05 | 44,612                                                                          | $                21.29                                   | 44,612                                                                                                                                                      |                                                                                                                                                                                |
| 8/01/05                - 8/31/05 | 9,000                                                                           |                   24.14                        | 9,000                                                                                                                                                       |                                                                                                                                                                                |
| 9/01/05                - 9/30/05 | 6,750                                                                           |                   24.36                        | 6,750                                                                                                                                                       |                                                                                                                                                                                |
| Total                            | 60,362                                                                          | $                22.06                                   | 60,362                                                                                                                                                      |                                                                                                                                                                                |

----

**Item      6. Exhibits **

| Exhibit                # | SECReference                # | Title                of Document                                                                                                                                                                 |
|--------------------------|-------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|                     |                          |                                                                                                                                                                                             |
| 1                        | 31                            | Certification                of CEO pursuant to Rule 13a-14(a) as adopted pursuant to Section                302 of                the Sarbanes-Oxley Act of 2002                                |
|                     |                          |                                                                                                                                                                                             |
| 2                        | 31                            | Certification                of Principal Financial Officer pursuant to Rule 13a-14(a) as adopted                pursuant to Section 302 of the Sarbanes-Oxley Act of                2002        |
|                     |                          |                                                                                                                                                                                             |
| 3                        | 32                            | Certification                of CEO pursuant to 18 U.S.C. §1350, as Adopted Pursuant to Section 906 of                the Sarbanes-Oxley Act of 2002                                        |
|                     |                          |                                                                                                                                                                                             |
| 4                        | 32                            | Certification                of Principal Financial Officer pursuant to 18 U.S.C. §1350, as Adopted                Pursuant to Section 906 of the Sarbanes-Oxley Act of                2002 |

|                                                                                                                                       | UTAH                MEDICAL PRODUCTS, INC. |
|--------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------|
|                                                                                                                                       | REGISTRANT                                 |
|                                                                                                                                       |                                       |   |
|                                                                                                                                       |                                       |   |
| Date:                         11/8/05            | By:                                        |                    /s/                Kevin L. Cornwell |
|                                                                                                                                       |                                       | Kevin                L. Cornwell |
|                                                                                                                                       |                                       | CEO |
|                                                                                                                                       |                                       |   |
|                                                                                                                                       |                                       |   |
| Date:                           11/8/05          | By:                                        |                    /s/                Greg A. LeClaire |
|                                                                                                                                       |                                       | Greg                A. LeClaire |
|                                                                                                                                       |                                       | CFO |

----